PL

Peter Lichtlen

EU Esbatech, An Alcon Biomedical Research Unit: 6 patents #5 of 16Top 35%
DA Delenex Therapeutics Ag: 2 patents #2 of 11Top 20%
CA Cell Medica Switzerland Ag: 1 patents #6 of 9Top 70%
SA Sucampo Ag: 1 patents #13 of 26Top 50%
📍 Adliswil, CH: #30 of 251 inventorsTop 15%
Overall (All Time): #511,098 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
9683034 Stable and soluble antibodies inhibiting TNFα Stefan Ewert, David Urech, Adrian Auf Der Maur, Alcide Barberis 2017-06-20
9512411 Nucleic acid encoding antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK Adrian Auf Der Maur, Alcide Barberis 2016-12-06
9315572 Stable and soluble antibodies inhibiting TNF alpha Stefan Ewert, Alcide Barberis, David Urech, Adrian Auf Der Maur 2016-04-19
8945563 Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK Adrian Auf Der Maur, Alcide Barberis 2015-02-03
8936785 scFv antibodies which pass epithelial and/or endothelial layers Adrian Auf Der Maur, Alcide Barberis, David Urech 2015-01-20
8835571 Fatty acid derivative-polymer conjugate Ryuji Ueno, Robert Gurny, Michael Möller 2014-09-16
8691228 Stable and soluble antibodies inhibiting TNFα Stefan Ewert, Alcide Barberis, David Urech, Adrian Auf Der Maur 2014-04-08
8389693 Stable and soluble antibodies inhibiting TNFα Stefan Ewert, Alcide Barberis, David Urech, Adrian Auf Der Maur 2013-03-05
8067547 Stable and soluble antibodies inhibiting TNFα Stefan Ewert, Alcide Barberis, David Urech, Adrian Auf Der Maur 2011-11-29
7902340 Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK Adrian Auf Der Maur, Alcide Barberis 2011-03-08